Bixiye
Ophthalmic Antihistamine - Commercial
Step Therapy
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1371 - 1380 ee natiijooyinka 3167
Bixiye
Elmiron® (pentosan polysulfate sodium) - Medicaid
Prior Authorization
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Bixiye
Elmiron® (pentosan polysulfate sodium) - Commercial
Prior Authorization
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Bixiye
Endari™ (Pharmaceutical Grade L-Glutamine (PGLG)) - Medicaid
Prior Authorization
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Bixiye
Erythropoietins - Commercial
Prior Authorization
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024
Bixiye
QP68-24 MHCP Pharmacy Benefit Exclusion for Kisunla™, PiaSky®, and Tecelra®
Taariikhda barnaamijka Dhaqangalayso Agosto 28, 2024
Bixiye
QP67-24 Commercial Pharmacy Benefit Exclusion for edaravone, Kisunla™, PiaSky®, and Tecelra®
Taariikhda barnaamijka Dhaqangalayso Agosto 28, 2024
Bixiye
QP65-24 PCA Agency Requirements
Taariikhda barnaamijka Dhaqangalayso Agosto 28, 2024
Bixiye
QP66-24 Reminder: Patient Complaint Policy and Process Requirements
Taariikhda barnaamijka Dhaqangalayso Agosto 28, 2024
Bixiye
QP62-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2024
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2024